Biostage, Inc.·4

Mar 26, 6:06 PM ET

CHAKOUTIS PETER M 4

4 · Biostage, Inc. · Filed Mar 26, 2020

Insider Transaction Report

Form 4
Period: 2020-03-24
CHAKOUTIS PETER M
Vice President of Finance
Transactions
  • Award

    Stock Option (right to buy)

    2020-03-24+40,00040,000 total
    Exercise: $4.00Exp: 2030-03-24Common Stock, par value $0.01 per share (40,000 underlying)
Footnotes (1)
  • [F1]This stock option vests as follows: (i) one quarter upon timely filing of the Company's Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2020, and (ii) the remainder in twelve (12) equal quarterly increments on the first day of each calendar quarter starting with the first calendar quarter following the timely filing of such Form 10-Q.

Documents

1 file
  • 4
    tm2013962d2_4.xmlPrimary

    OWNERSHIP DOCUMENT